Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Drug Delivery Science and Technology"
DOI: 10.1016/j.jddst.2020.102210
Abstract: ABSTRACT Doxazosin Mesylate (DOX) is an antihypertensive drug which possesses poor water solubility and hence low bioavailability. The study objective is to prepare DOX fast disintegrating tablets as a new dosage form for geriatric patients.…
read more here.
Keywords:
disintegrating tablet;
nanosuspension;
fast disintegrating;
doxazosin mesylate ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Drug Development and Industrial Pharmacy"
DOI: 10.1080/03639045.2019.1597105
Abstract: Abstract Objective: Control the release and enhance the bioavailability of chitosan-doxazosin mesylate nanoparticles (DM-NPs). Significance: Improve DM bioavailability for the treatment of benign prostatic hyperplasia and hypertension. Methods: Plackett–Burman design was utilized to screen the…
read more here.
Keywords:
controlling release;
bioavailability;
drug;
doxazosin mesylate ... See more keywords